Market News & Trends
Veru Announces FDA Grant of Fast Track Designation for Enobosarm for the Treatment of AR+ ER+ HER2- Metastatic Breast Cancer
Veru Inc. recently announced the US FDA has granted Fast Track designation to the Phase 3 registration program for the investigation of enobosarm, a selective androgen receptor targeting agonist, for the treatment of….
Castle Creek Biosciences Acquires Novavita Thera to Expand Innovative Cell & Gene Therapy Platform
Castle Creek Biosciences, Inc. recently announced it has acquired Novavita Thera, Inc., a preclinical gene therapy company focused on rare liver and metabolic diseases. The…
Adare Pharma Solutions Announces Appointment of Tom Sellig as Chief Executive Officer
Adare Pharma Solutions recently announced the appointment of Tom Sellig as Chief Executive Officer (CEO). Sellig, a 30-year veteran of the pharmaceutical and life sciences industries, will lead the….
Eisai Enters Into Exclusive Licensing Agreement With Roivant Concerning Investigational Anticancer Agent H3B-8800, a Splicing Modulator
Eisai Co., Ltd. recently announced it has entered into a License Agreement granting the exclusive rights for global research, development, manufacture and sale of the…
Univercells Acquires SynHelix, Entering Into Synthetic Biology & the Race to Next-Generation DNA Synthesis
Univercells S.A. (Univercells) recently announced its acquisition of SynHelix, a biotechnology company that aims to debottleneck biotherapeutics development through an unprecedented robust, scalable, and….
Sosei Heptares & Verily to Collaborate to Generate Novel Drug Candidates Against GPCR Targets for Immune-Mediated Diseases
Sosei Group Corporation and Verily recently announced they have entered into a strategic research collaboration. The research agreement brings together the….
AVITA Medical Establishes Proof-of-Concept for Novel Treatments Using Genetically Modified Skin Cells
AVITA Medical, Inc. recently announced that preclinical data successfully established proof-of-concept in two key areas of cell-based gene therapy – skin rejuvenation and….
Biomea Fusion Releases Preclinical Data With BMF-219 in Diabetes
Biomea Fusion, Inc. recently announced BMF-219 displayed remarkable activity in both the Zucker Diabetic Fatty (ZDF) Rat and the Streptozotocin-Induced Diabetes (STZ) animal models of…
Aceragen Announces $3.5-Million Development Award from Cystic Fibrosis Foundation to Progress Novel Therapy for CF-Related Exacerbations
Aceragen, Inc. recently announced that its wholly owned subsidiary, Arrevus, Inc., has received an award from the Cystic Fibrosis Foundation for up to $3.5 million…
Moderna Announces First Participant Dosed in Phase 1 Study of its Epstein-Bar Virus Vaccine
Moderna, Inc. recently announced the first participant has been dosed in the Phase 1 study of mRNA-1189, the Company's Epstein-Barr Virus (EBV) vaccine candidate. The study…
Covis Completes Acquisition of Global Respiratory Portfolio of Two Medicines From AstraZeneca
Covis Pharma Group recently announced Covis Pharma GmbH has completed the acquisition of Eklira (aclidinium bromide), known as Tudorza in the US and marketed as Bretaris in some countries, and….
PhoreMost & POLARISqb Announce a Multi-Target Collaboration to Investigate Next-Generation Cancer Therapies
PhoreMost Limited and Polaris Quantum Biotech recently announced a collaboration to study oncology targets currently considered undruggable. Under the terms of the agreement, the POLARISqb…
MannKind Extends Collaboration With Thirona Bio on Fibrotic Lung Diseases
MannKind Corporation recently announced that has extended its collaboration with Thirona Bio, Inc. with the purchase of a second convertible note issued by Thirona, and the appointment of….
Pfizer & BioNTech Sign New Global Collaboration Agreement to Develop First mRNA-based Shingles Vaccine
Pfizer Inc. and BioNTech SE recently announced a new research, development, and commercialization collaboration to develop a potential first mRNA-based vaccine for the prevention of shingles….
Akoya Biosciences & Bio-Techne Partner to Deliver Automated Spatial Multiomics Workflow With Industry-Leading Speed & Resolution
Akoya Biosciences, Inc. and Bio-Techne recently announced a partnership to develop the first single-cell, spatial multiomics workflow for comprehensive, unbiased analysis of tissue samples. Through…
MariMed Announces Agreement to Acquire Kind Therapeutics USA, LLC
MariMed Inc. recently announced it has entered into a definitive agreement to acquire Kind Therapeutics U.S.A., LLC. The transaction is subject to customary closing conditions,…
Rain Therapeutics & Roche to Collaborate on Clinical Trial of Milademetan Combination With Anti-PD-L1 Immunotherapy for Various Solid Tumor Indications
Rain Therapeutics Inc. recently announced a clinical supply agreement with Roche for the supply of the anti-Programmed Death Ligand-1 (PD-L1) monoclonal antibody, atezolizumab…..
F-star Therapeutics Announces Merck KGaA, Darmstadt, Germany Exercises a Fourth Licensing Option in Immuno-Oncology Collaboration
F-star Therapeutics, Inc. recently announced that Ares Trading S.A., an affiliate of Merck KGaA, Darmstadt, Germany, has exercised a fourth licensing option to develop another…
Cue Biopharma & LG Chem Life Sciences Announce Development Milestone in Immuno-STAT Biologics Collaboration for CUE-102
Cue Biopharma, Inc. and LG Chem Life Sciences recently announced a key milestone in the selection of a clinical product candidate has been reached in their collaboration for CUE-102, an Immuno-STAT biologic, jointly developed to….
Curia Unveils Comprehensive mRNA Solution
Curia, formerly AMRI, a leading contract research, development and manufacturing organization, recently unveiled its messenger RNA (mRNA) solution, which includes discovery, process development and mRNA drug substance production, through….
